1. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023) Authors: Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kilad... Journal: Lancet Issue: Volume 401:Issue 10373(2023) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Results of a Phase 1/2a dose–escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes. Issue 8 (2nd July 2020) Authors: Garcia-Manero, Guillermo; Pemmaraju, Naveen; Alvarado, Yesid; Naqvi, Kiran; Ravandi, Farhad; Jabbour, Elias; De Lumpa, Ricardo; Kantarjian, Hagop; Advani, Anjali; Mukherjee, Sudipto; Gerds, Aaron; Carraway, Hetty E.; Nazha, Aziz; Iwamura, Hiroyuki; Murase, Motohiko; Bavisotto, Linda; Kurman, Mich... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States. (4th February 2022) Authors: Copher, Ronda; Kee, Arianna; Gerds, Aaron Journal: Oncologist Issue: Volume 27:Number 3(2022) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗